Literature DB >> 19920190

Siah proteins: novel drug targets in the Ras and hypoxia pathways.

Colin M House1, Andreas Möller, David D L Bowtell.   

Abstract

The Siah (seven in absentia homolog) family of RING-domain proteins are components of ubiquitin ligase complexes, targeting proteins for proteasomal degradation. Siah family members have been reported to function in Ras, estrogen, DNA-damage, and hypoxia response pathways. Although earlier reports implicated Siah proteins as tumor suppressors, recent studies in mouse models have shown that Siah inhibition impairs tumor growth and metastasis. Given their central role in oncogenic and angiogenic pathways, Siah proteins are attractive novel therapeutic targets in cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19920190     DOI: 10.1158/0008-5472.CAN-09-1676

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  43 in total

1.  Herpes simplex virus immediate-early protein ICP0 is targeted by SIAH-1 for proteasomal degradation.

Authors:  Claus-Henning Nagel; Nina Albrecht; Kristijana Milovic-Holm; Lakshmikanth Mariyanna; Britta Keyser; Bettina Abel; Britta Weseloh; Thomas G Hofmann; Martha M Eibl; Joachim Hauber
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Lotus japonicus E3 ligase SEVEN IN ABSENTIA4 destabilizes the symbiosis receptor-like kinase SYMRK and negatively regulates rhizobial infection.

Authors:  Griet Den Herder; Satoko Yoshida; Meritxell Antolín-Llovera; Martina K Ried; Martin Parniske
Journal:  Plant Cell       Date:  2012-04-24       Impact factor: 11.277

3.  CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2.

Authors:  C García-Limones; M Lara-Chica; C Jiménez-Jiménez; M Pérez; P Moreno; E Muñoz; M A Calzado
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

4.  Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.

Authors:  Tapasree Roy Sarkar; Shikha Sharan; Jun Wang; Snehalata A Pawar; Carrie A Cantwell; Peter F Johnson; Deborah K Morrison; Ju-Ming Wang; Esta Sterneck
Journal:  Mol Cell Biol       Date:  2011-10-28       Impact factor: 4.272

5.  Deletion of Siah-interacting protein gene in Drosophila causes cardiomyopathy.

Authors:  Michelle E Casad; Lin Yu; Joseph P Daniels; Matthew J Wolf; Howard A Rockman
Journal:  Mol Genet Genomics       Date:  2012-03-08       Impact factor: 3.291

Review 6.  RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesis.

Authors:  Stanley Lipkowitz; Allan M Weissman
Journal:  Nat Rev Cancer       Date:  2011-08-24       Impact factor: 60.716

Review 7.  The Siah2-HIF-FoxA2 axis in prostate cancer – new markers and therapeutic opportunities.

Authors:  Jianfei Qi; Maurizio Pellecchia; Ze'ev A Ronai
Journal:  Oncotarget       Date:  2010-09

8.  SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation.

Authors:  M Buchwald; K Pietschmann; P Brand; A Günther; N P Mahajan; T Heinzel; O H Krämer
Journal:  Oncogene       Date:  2012-12-03       Impact factor: 9.867

9.  SIAH2 protein expression in breast cancer is inversely related with ER status and outcome to tamoxifen therapy.

Authors:  Kimberly D van der Willik; Mieke M Timmermans; Carolien Hm van Deurzen; Maxime P Look; Esther A Reijm; Wendy Jhp van Zundert; Renée Foekens; Anita Mac Trapman-Jansen; Michael A den Bakker; Pieter J Westenend; John Wm Martens; Els Mjj Berns; Maurice Phm Jansen
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

10.  Structure-based design of covalent Siah inhibitors.

Authors:  John L Stebbins; Eugenio Santelli; Yongmei Feng; Surya K De; Angela Purves; Khatereh Motamedchaboki; Bainan Wu; Ze'ev A Ronai; Robert C Liddington; Maurizio Pellecchia
Journal:  Chem Biol       Date:  2013-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.